Loeb Partners’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Loeb Partners's DGX Position: Q1 2019 in Review
Loeb Partners sold out of Quest Diagnostics (DGX) in Q1 2019, closing a stake of 3,500 shares — an estimated $291K sold.
Loeb Partners first reported a position in DGX in Q2 2016 and held it in 11 quarters. The position peaked at $770K in Q2 2018. 657 funds tracked by Wall St. Rank hold DGX as of Q1 2019.
- Loeb Partners reported no remaining Quest Diagnostics position as of Q1 2019 after selling out during the quarter.
- Loeb Partners sold 3,500 Quest Diagnostics shares in Q1 2019, an estimated $291K.
- Loeb Partners first reported a position in Quest Diagnostics in Q2 2016 and held it in 11 quarters.
- Loeb Partners's Quest Diagnostics position peaked at $770K in Q2 2018.
- 657 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2019.
Based on Loeb Partners's 13F filing for Q1 2019, filed 14 May 2019.